Debi Watson
Direktor/Vorstandsmitglied bei Artera, Inc.
Profil
Debi Watson is currently a Vice President at Johnson & Johnson Innovation - JJDC, Inc., as well as a Board Member at Serotiny, Inc., Trex Bio, Inc., Rondo Therapeutics, Inc., Perceive Biotherapeutics, Inc., and Artera, Inc. Previously, she was a Vice President at Janssen Pharmaceuticals, Inc. from 1991 to 2013, and then at Johnson & Johnson Innovation LLC from 2013 to 2021.
She received her undergraduate degree from the University of Connecticut.
Aktive Positionen von Debi Watson
Unternehmen | Position | Beginn |
---|---|---|
Johnson & Johnson Innovation - JJDC, Inc.
Johnson & Johnson Innovation - JJDC, Inc. Investment ManagersFinance Johnson & Johnson Innovation JJDC Inc (Johnson & Johnson Innovation JJDC) is a venture capital subsidiary of Johnson & Johnson founded in 1973. The firm is headquartered in New Brunswick, New Jersey. | Private Equity Investor | 01.07.2021 |
Artera, Inc.
Artera, Inc. Information Technology ServicesTechnology Services Artera, Inc. is an American artificial intelligence company that provides cancer therapy services. The company was founded by Andre Esteva and he has been the CEO since incorporation. | Direktor/Vorstandsmitglied | 01.03.2023 |
Serotiny, Inc.
Serotiny, Inc. Miscellaneous Commercial ServicesCommercial Services Serotiny, Inc. is an ecological adaptation exhibited by some seed plants. The company was founded in Justin Farlow and Colin Farlow and is headquartered in San Francisco, CA. | Direktor/Vorstandsmitglied | 01.03.2023 |
Perceive Biotherapeutics, Inc.
Perceive Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Perceive Biotherapeutics, Inc. is a biotech company that is focused on developing a diverse pipeline of targets and treatment modalities for various therapeutic verticals, with a particular emphasis on ophthalmology. The company is based in South San Francisco, CA. Perceive is backed by Deerfield Management and is planning to raise a series B later this year. The company was founded based on research that identified two novel protective biologies for treating retinal blindness, which were developed from collaborations in genetic science and target validation. Kristen Angela MacFarlane has been the CEO of the company since 2020. | Direktor/Vorstandsmitglied | 01.01.2023 |
Rondo Therapeutics, Inc.
Rondo Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Rondo Therapeutics, Inc. develops bispecific therapeutic antibodies to fight cancer. The American company was founded by Nathan D. Trinklein, Shelley Force Aldred. Shelley Force Aldred has been the CEO since incorporation. | Direktor/Vorstandsmitglied | 01.01.2022 |
Trex Bio, Inc.
Trex Bio, Inc. Pharmaceuticals: MajorHealth Technology Trex Bio, Inc. manufactures immunotherapies for autoimmune and inflammatory diseases. The company is headquartered in South San Francisco, CA. | Direktor/Vorstandsmitglied | 01.10.2021 |
Ehemalige bekannte Positionen von Debi Watson
Unternehmen | Position | Ende |
---|---|---|
Johnson & Johnson Innovation LLC
Johnson & Johnson Innovation LLC Medical/Nursing ServicesHealth Services Part of Johnson & Johnson, Johnson & Johnson Innovation LLC focuses on accelerating innovation worldwide and forming collaborations between entrepreneurs and Johnson & Johnson's healthcare businesses. The company is based in South San Francisco, CA. Johnson & Johnson Innovation provides scientists, entrepreneurs, and emerging companies with one-stop access to science and technology experts who can facilitate collaborations across the pharmaceutical, medical device, and consumer companies of Johnson & Johnson. The company connects with innovators through its regional innovation centers, Johnson & Johnson Innovation - JLABS, JJDC, Inc., and its business development teams to create customized deals and novel collaborations that speed up the development of innovations to solve unmet needs in patients. JLABS provides the laboratories, expertise, education, tools, and resources needed to help life science startups thrive, all with no strings attached. Johnson & Johnson Innovation Center for Device Innovation at the Texas Medical Center (CDI @ TMC) has been established to accelerate the development of medical devices. | Corporate Officer/Principal | 01.07.2021 |
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Corporate Officer/Principal | 01.05.2013 |
Ausbildung von Debi Watson
University of Connecticut | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 8 |
---|---|
Johnson & Johnson Innovation - JJDC, Inc.
Johnson & Johnson Innovation - JJDC, Inc. Investment ManagersFinance Johnson & Johnson Innovation JJDC Inc (Johnson & Johnson Innovation JJDC) is a venture capital subsidiary of Johnson & Johnson founded in 1973. The firm is headquartered in New Brunswick, New Jersey. | Finance |
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Health Technology |
Johnson & Johnson Innovation LLC
Johnson & Johnson Innovation LLC Medical/Nursing ServicesHealth Services Part of Johnson & Johnson, Johnson & Johnson Innovation LLC focuses on accelerating innovation worldwide and forming collaborations between entrepreneurs and Johnson & Johnson's healthcare businesses. The company is based in South San Francisco, CA. Johnson & Johnson Innovation provides scientists, entrepreneurs, and emerging companies with one-stop access to science and technology experts who can facilitate collaborations across the pharmaceutical, medical device, and consumer companies of Johnson & Johnson. The company connects with innovators through its regional innovation centers, Johnson & Johnson Innovation - JLABS, JJDC, Inc., and its business development teams to create customized deals and novel collaborations that speed up the development of innovations to solve unmet needs in patients. JLABS provides the laboratories, expertise, education, tools, and resources needed to help life science startups thrive, all with no strings attached. Johnson & Johnson Innovation Center for Device Innovation at the Texas Medical Center (CDI @ TMC) has been established to accelerate the development of medical devices. | Health Services |
Artera, Inc.
Artera, Inc. Information Technology ServicesTechnology Services Artera, Inc. is an American artificial intelligence company that provides cancer therapy services. The company was founded by Andre Esteva and he has been the CEO since incorporation. | Technology Services |
Serotiny, Inc.
Serotiny, Inc. Miscellaneous Commercial ServicesCommercial Services Serotiny, Inc. is an ecological adaptation exhibited by some seed plants. The company was founded in Justin Farlow and Colin Farlow and is headquartered in San Francisco, CA. | Commercial Services |
Perceive Biotherapeutics, Inc.
Perceive Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Perceive Biotherapeutics, Inc. is a biotech company that is focused on developing a diverse pipeline of targets and treatment modalities for various therapeutic verticals, with a particular emphasis on ophthalmology. The company is based in South San Francisco, CA. Perceive is backed by Deerfield Management and is planning to raise a series B later this year. The company was founded based on research that identified two novel protective biologies for treating retinal blindness, which were developed from collaborations in genetic science and target validation. Kristen Angela MacFarlane has been the CEO of the company since 2020. | Health Technology |
Rondo Therapeutics, Inc.
Rondo Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Rondo Therapeutics, Inc. develops bispecific therapeutic antibodies to fight cancer. The American company was founded by Nathan D. Trinklein, Shelley Force Aldred. Shelley Force Aldred has been the CEO since incorporation. | Commercial Services |
Trex Bio, Inc.
Trex Bio, Inc. Pharmaceuticals: MajorHealth Technology Trex Bio, Inc. manufactures immunotherapies for autoimmune and inflammatory diseases. The company is headquartered in South San Francisco, CA. | Health Technology |